Postmortem distribution of sildenafil in histological material

Journal of Analytical Toxicology

Volumn 29, Issue 4, 2005, Pages 254-257

  Pagani, Stefania ^a   Mirtella, Dora ^b   Mencarelli, Roberto ^a   Rodriguez, Daniele ^a   Cingolani, Mariano ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF MACERATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; SILDENAFIL;

ACUTE HEART FAILURE; ADULT; ARTICLE; AUTOPSY; BODY FLUID; BRAIN; CASE REPORT; CAUSE OF DEATH; DRUG BILE LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG INTOXICATION; DRUG STABILITY; DRUG TISSUE LEVEL; DRUG URINE LEVEL; HEART; HEART MUSCLE FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY; LIVER; LUNG; MALE; PILL; SPLEEN; STOMACH CONTENT; TISSUE FIXATION;

EID: 20444446700     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.4.254     Document Type: Article

References (20)

1. Food and Drug Administration. Approves impotence pill, Viagra. National Press Office, Rockville, MD, 1998.
2. E.G. Boyce and E.M. Umland. Sildenafil citrate: a therapeutic update. Clin. Ther. 23: 2-23 (2001).
3. Pfizer processing data on IMS Health (2003).
4. R.A. Kloner and R.M. Zusman. Cardiovascular effects of sildenafil citrate and recommendations for its use. Am. J. Cardiol. 84: 11-17 (1999).
5. H. Sperling, M.C. Michel, and H. Rubben. Viagra: tolerance, contraindications and drug interactions, (in German). Urologe A 38: 124-127 (1999).
6. Food and Drug Administration FDA. Summary of reports of death in Viagra users received from marketing (late March) through mid-November, National Press Office, Rockville, MD, 1998.
7. B. Azarbal, J. Mirocha, P. Shah, B. Cercek, and S. Kaul. Adverse cardiovascular events associated with the use of Viagra. J. Am. Coll. Cardiol. 35 (Suppl. A): 553-554 (2000).
8. H. Morrison. Sildenafil (Viagra): cardiac risks. Canadian Adverse Drug Reaction Newsletter 10(3): 4-6 (2000).
9. M. Mitka. Some men who take Vigara die - why? J. Am. Med. Assoc. 283: 590-593 (2000).
10. K. Armstrong, J.S. Schwatrz, and D.A. Asch. Direct sale of sildenafil (Viagra) to consumers over the internet. N. Engl. J. Med. 341: 1389-1392 (1999).
11. S.E. Kahan, A.D. Seftel, and M.I. Resnick. Sildenafil and the internet. J. Urol. 163: 919-923 (2000).
12. V. Dumestre-Toulet, V. Cirimele, S. Gromb, T. Beloousoff, D. Lavault, B. Ludes, and P. Kintz. Last performance with Viagra: post-mortem identification of sildenafil and its metabolites in biological specimens including hair sample. Forensic Sci. Int. 126: 71-76 (2002).
13. T.L. Ng, S.T. Chow, Y.J. Yao, T.H. Koh, and D.S.T. Lo. Sildenafil detected in urine of first Viagra related death in Singapore. Bull. Int. Assoc. Forensic Toxicol. 29: 20-22 (1999).
14. W. Weinman, M. Bohnert, A. Weidemann, M. Renz, N. Lehmann, and S. Pollak. Post-mortem detection and identification of sildenafil (Viagra) and its metabolites by LC/MS and LC/MS/MS. Int. J. Legal Med. 114: 252-258 (2001).
15. A. Tracqui and B. Ludes. HPLC-MS for the determination of sildenafil citrate (Viagra) in biological fluids. Application to the salivary excretion of sildenafil after oral intake. J. Anal. Toxicol. 27: 88-94 (2003).
16. D.K. Walker, M.J. Ackland, G.C. James, G.J. Muirhead, D.J. Rance, P. Wastall, and P.A. Wright. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 29: 297-310 (1999).
17. M. Cingolani, R. Froldi, R. Mencarelli, D. Mirtella, and D. Rodriguez. Detection and quantitation of morphine in fixed tissues and formalin solutions. J. Anal. Toxicol. 25: 31-34 (2001).
18. M. Cingolani, R. Froldi, R. Mencarelli, and D. Rodriguez. Analytical detection and quantitation of strychnine in chemically fixed organ tissues. J. Anal. Toxicol. 23: 219-221 (1999).
19. Italian Pharmaceutical Index (REFI), Viagra, OVP Ed., Milan, Italy, 2000, pp 2614-2615.
20. M.B. Noss, G.J. Christ, and A. Melman. Sildenafil: a new oral therapy for erectile disfunction. Drugs Today 35(3): 211-217 (1999).